A new study published in Nature reveals that artificial intelligence models can now predict protein folding with near-experimental accuracy, a breakthrough with significant implications for drug discovery and disease research. The AI system, developed by DeepMind, outperformed all previous computational methods in a biennial competition, solving structures for dozens of proteins. Researchers highlight that this advancement could drastically accelerate the understanding of biological processes and the development of new therapeutics. The findings suggest AI is poised to become a standard tool in structural biology. For the full details, read the complete article at https://example.com/full-article.